Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05914064 · ClinicalTrials.gov registry record · NA
Gravitas Feeding Tube System Placement Validation in Neonates
A NA study of Nasogastric Tube, sponsored by Gravitas Medical.
- Active
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 5
- Study locations
NCT05914064: Active NA study of Nasogastric Tube, sponsored by Gravitas Medical.
NCT05914064 is a NA study of Nasogastric Tube that is active but no longer recruiting, run by Gravitas Medical. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05914064, a NA study of Nasogastric Tube, is active but no longer recruiting, sponsored by Gravitas Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to validate the Gravitas Feeding Tube System Placement Algorithm for NICU patients and to evaluate the safety and effectiveness of the Gravitas Feeding Tube in the neonate population for the administration of nutrition, fluids and medications.
Conditions Studied
Interventions
- DEVICE Gravitas FT and Gravitas FT Monitor guidance
Study Locations (5)
California
- Lucile Packard (Stanford) Children's Hospital - Stanford
Georgia
- Memorial Health University Medical Center - Savannah
Massachusetts
- Boston Children's Hospital - Boston
Rhode Island
- Women & Infants Hospital, Rhode Island - Providence
Virginia
- University of Virginia Children's Health - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-10-27 |
| Est. Completion | 2026-12 |
| Phase | NA |
What the registry record for NCT05914064 still lists
NCT05914064 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Nasogastric Tube appearing as the primary indexed condition, and to 1 intervention - of which Gravitas FT and Gravitas FT Monitor guidance is the first listed.
NCT05914064 lists 5 locations in 5 states (California, Georgia, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT05914064 about?
NCT05914064 is a clinical study titled "Gravitas Feeding Tube System Placement Validation in Neonates". The purpose of this study is to validate the Gravitas Feeding Tube System Placement Algorithm for NICU patients and to evaluate the safety and effectiveness of the Gravitas Feeding Tube in the neonate population for the administration of nutrition, fluids and medications.
What is the current status of trial NCT05914064?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-10-27. Estimated completion is 2026-12.
What conditions does trial NCT05914064 study?
This clinical trial studies the following conditions: Nasogastric Tube.
What interventions are being tested in trial NCT05914064?
The interventions under investigation include: Gravitas FT and Gravitas FT Monitor guidance (DEVICE).
Who is sponsoring clinical trial NCT05914064?
This trial is sponsored by Gravitas Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05914064 being conducted?
This trial has 5 study locations across California, Georgia, Massachusetts, Rhode Island, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05914064's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI